| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/03/2002 | CA2452183A1 Methods and compositions for highly effective transformation of filamentous fungi |
| 01/03/2002 | CA2417699A1 Helicobacter pylori heptosyl transferase polypeptides |
| 01/03/2002 | CA2415761A1 Novel human gaba receptors and polynucleotides encoding the same |
| 01/03/2002 | CA2415238A1 Peptides for the preparation of vaccines against bordetella pertussis and bordetella parapertussis |
| 01/03/2002 | CA2414588A1 Nucleic acids coding for a plant phosphatase of the mipp type with phytase activity and uses |
| 01/03/2002 | CA2414396A1 Production of vaccines using transgenic plants |
| 01/03/2002 | CA2414382A1 Esr1 - a plant gene that can promote plant regeneration and transformation |
| 01/03/2002 | CA2414308A1 Transport peptides derived from erns protein, cytotoxic rnase of ribosome-inactivating protein or a rsv g-protein and analogues thereof |
| 01/03/2002 | CA2414210A1 Novel therapeutic molecular variants and uses thereof |
| 01/03/2002 | CA2414137A1 Recombinant saccharomyces cerevisiae expressing chimeric glucose transporters |
| 01/03/2002 | CA2414098A1 Human site-1 protease promoter |
| 01/03/2002 | CA2414077A1 Virus vector for introducing gene into renal cells |
| 01/03/2002 | CA2413800A1 Manipulation of negative stranded rna viruses by rearrangement of their genes and uses thereof |
| 01/03/2002 | CA2413786A1 Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes |
| 01/03/2002 | CA2413747A1 Mammal 2p domain mechano-sensitive k+ channel, cloning and applications thereof |
| 01/03/2002 | CA2413673A1 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 01/03/2002 | CA2413596A1 Cell lines and cell-based assays for identification of androgen receptor modulators |
| 01/03/2002 | CA2413547A1 B7-like molecules and uses thereof |
| 01/03/2002 | CA2413543A1 Human papilloma virus treatment |
| 01/03/2002 | CA2413449A1 Altered wool and hair fibres |
| 01/03/2002 | CA2413425A1 Binary vectors for improved transformation of plant systems |
| 01/03/2002 | CA2413209A1 Modulation of a.beta. levels by .beta.-secretase bace2 |
| 01/03/2002 | CA2413049A1 Changing the fine chemical content in organisms by genetically modifying the shikimate pathway |
| 01/03/2002 | CA2412721A1 Methods and compositions for transcription-based nucleic acid amplification |
| 01/03/2002 | CA2412701A1 Methods for producing modified glycoproteins |
| 01/03/2002 | CA2412637A1 Replication deficient adenoviral tnf vector |
| 01/03/2002 | CA2412635A1 Novel proteases |
| 01/03/2002 | CA2412621A1 Rescue of canine distemper virus from cdna |
| 01/03/2002 | CA2412612A1 Eg-vegf nucleic acids and polypeptides and methods of use |
| 01/03/2002 | CA2412610A1 Gp286 nucleic acids and polypeptides |
| 01/03/2002 | CA2412256A1 Polynucleotides and polypeptides encoded thereby |
| 01/03/2002 | CA2412239A1 Cytokine receptor zcytor17 |
| 01/03/2002 | CA2412211A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/03/2002 | CA2412089A1 Prostase protein vaccine comprising derivatised thiol residues and methods for producing said antigen |
| 01/03/2002 | CA2412084A1 Triple fusion proteins comprising ubiquitin fused between thioredoxin and a polypeptide of interest |
| 01/03/2002 | CA2411828A1 Novel co-stimulatory molecules |
| 01/03/2002 | CA2411515A1 Generation of libraries of antibodies in yeast and uses thereof |
| 01/03/2002 | CA2411479A1 Methods and compositions for simultaneous saccharification and fermentation |
| 01/03/2002 | CA2411167A1 Polynucleotide vaccine adjuvants and formulations containing cationic surfactants, and methods of use |
| 01/03/2002 | CA2410951A1 Multiply-primed amplification of nucleic acid sequences |
| 01/03/2002 | CA2410575A1 Antimicrobial peptides of the family of defensins, polynucleotides encoding said peptides, transformed vectors and organisms containing them |
| 01/03/2002 | CA2410388A1 Use of compositions consisting of cationic compounds and proton donors for stabilising and/or isolating nucleic acids in or from micro-organisms such as prokaryotes, fungi, protozoa or algae |
| 01/03/2002 | CA2410284A1 Nucleotide sequence of influenza a/udorn/72 (h3n2) genome |
| 01/03/2002 | CA2410159A1 Heterologous gene expression in plants |
| 01/03/2002 | CA2409408A1 Modulation of chromosome function by chromatin remodeling agents |
| 01/03/2002 | CA2408326A1 Recombinant constructs and their use in reducing gene expression |
| 01/03/2002 | CA2381338A1 Human lyases |
| 01/03/2002 | CA2381241A1 Truncated egf receptor |
| 01/02/2002 | EP1167544A2 Probe for diagnosing infectious disease arising from Escherichia coli, Klebsiella pneumoniae or Enterobacter cloacae |
| 01/02/2002 | EP1167543A2 Probe for diagnosing infectious disease arising from Staphylococcus epidermidis |
| 01/02/2002 | EP1167542A2 Probe for diagnosing infectious disease arising from Enterococcus faecalis |
| 01/02/2002 | EP1167537A1 Process for producing monoclonal antibody |
| 01/02/2002 | EP1167533A1 Methods and means for the complementation of viral protein expression in stable cell lines |
| 01/02/2002 | EP1167532A2 Edible transgenic plants expressing mammalian proteins |
| 01/02/2002 | EP1167531A1 Corn transformant PV-ZMGT32 (NK603) and compositions and methods for detection thereof |
| 01/02/2002 | EP1167530A2 PVX capsid-antigen fusion protein, chimaeric viral particles displaying it on the capsid, plants infected with said particles, their uses and compositions comprising them |
| 01/02/2002 | EP1167529A2 Vector system for introducing DNA into eucaryotic cells |
| 01/02/2002 | EP1167528A1 Botrytis cinerea laccase |
| 01/02/2002 | EP1167527A1 Processed human chemokines PHC-1 and PHC-2 |
| 01/02/2002 | EP1167526A1 IgE-dependent histamine-releasing factor(HRF)receptor, HRF-binding peptides and nucleic acids encoding the same, and uses thereof |
| 01/02/2002 | EP1167525A1 Cyk-4 polypeptides, DNA molecules encoding them and their use in screening methods |
| 01/02/2002 | EP1167524A1 Method for amplifying nucleic acid sequence |
| 01/02/2002 | EP1167523A2 Insertion sequence elements derived from ralstonia solanacearum |
| 01/02/2002 | EP1167522A1 Method for screening biomolecule activity regulator |
| 01/02/2002 | EP1167520A2 Method for the fermentative production of D-pantothenic acid by using coryneform bacterium |
| 01/02/2002 | EP1167519A1 Glucose dehydrogenase |
| 01/02/2002 | EP1167388A1 Single-stranded fv inducing apoptosis |
| 01/02/2002 | EP1167386A1 Canine and feline melanocortin-4 receptor sequences and screening assays to identify compounds useful in regulating animal appetite and metabolic rate |
| 01/02/2002 | EP1167385A2 Human follicle stimulating hormone receptor |
| 01/02/2002 | EP1167384A1 HVEGF Receptor as Vascular endothelial cell growth factor antagonists |
| 01/02/2002 | EP1167379A2 Immunomodulatory oligonucleotides |
| 01/02/2002 | EP1167378A2 Immunomodulatory oligonucleotides |
| 01/02/2002 | EP1167377A2 Immunomodulatory oligonucleotides |
| 01/02/2002 | EP1167345A1 Method of purifying amide compound |
| 01/02/2002 | EP1166797A1 Method of controlling the qualities of attenuated pox vaccine |
| 01/02/2002 | EP1166775A2 Targeted liposome gene delivery |
| 01/02/2002 | EP1166121A1 Selection of intracellular immunoglobulins |
| 01/02/2002 | EP1166102A1 Heart abnormalities in vascular endothelial growth factor b (vegf-b) deficient animals and methods relating to these heart abnormalities |
| 01/02/2002 | EP1165842A1 Lentiviral vector system for high quantity screening |
| 01/02/2002 | EP1165840A1 Mutations associated with iron disorders |
| 01/02/2002 | EP1165839A2 Universal arrays |
| 01/02/2002 | EP1165838A2 Coupled polymerase chain reaction-restriction endonuclease digestion-ligase detection reaction process |
| 01/02/2002 | EP1165837A2 Method for mapping a dna molecule comprising an $i(ad infinitum) amplification step |
| 01/02/2002 | EP1165836A2 Schizophrenia associated genes, proteins and biallelic markers |
| 01/02/2002 | EP1165830A1 Adipose-derived stem cells and lattices |
| 01/02/2002 | EP1165828A1 50 human secreted proteins |
| 01/02/2002 | EP1165827A1 45 human secreted proteins |
| 01/02/2002 | EP1165823A1 cDNA SYNTHESIS IMPROVEMENTS |
| 01/02/2002 | EP1165819A2 Delivery of functional protein sequences by translocating polypeptides |
| 01/02/2002 | EP1165818A2 Therapy of cancer by insect cells containing recombinant baculovirus encoding genes |
| 01/02/2002 | EP1165817A1 Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration |
| 01/02/2002 | EP1165816A2 Insect viral vectors and uses thereof |
| 01/02/2002 | EP1165815A1 Chimeric expression promoters originating from commelina yellow mottle virus and cassava vein mosaic virus |
| 01/02/2002 | EP1165814A2 Ve protein and nucleic acid sequences, compositions, and methods for plant pathogen resistance |
| 01/02/2002 | EP1165813A2 Linear and circular expression elements |
| 01/02/2002 | EP1165812A2 Protozoan expression system |
| 01/02/2002 | EP1165811A2 Multiple component rna vector system for expression of foreign sequences |
| 01/02/2002 | EP1165810A2 Transducing phages |
| 01/02/2002 | EP1165809A2 Leukotriene b4 receptor transgenic mammals |
| 01/02/2002 | EP1165808A2 Dna binding compound-mediated molecular switch system |